Solvay and Invista Renew their ADN Joint Venture Agreement
Solvay and Invista have renewed their joint venture agreement to manufacture adiponitrile (ADN), a key intermediate in the production of Polyamide 6.6.
This long-term agreement clarifies the rules of control and operations of Butachimie, in which both companies own a 50 percent stake. Butachimie operates the world's largest ADN production facility in Chalampé, France. Both parties have agreed that Butachimie would benefit from the latest and best available butadiene-based ADN technology, which is owned exclusively by Invista.
The agreement also gives Solvay an option to reserve capacity in the new ADN plant Invista plans to build in China.
Would you like to subscribe to our Newsletters on plastics technology and profit from the latest information?
Looking for a new challenge? Check out our jobs market!
Patents encourage innovation: Stay on the ball with the latest innovations in the plastics industry in our patents section.